OneRay Key Updates Delivering Next-Generation GenAI Capabilities

 

Our private gen AI solution OneRay comes with significant updates in Version 3, introducing enhanced AI capabilities and an expanded suite of specialized agents for pharmaceutical knowledge work.

We’re pleased to share the key updates now available in OneRay Version 3, delivering a series of transformative enhancements to our GenAI platform that reinforce our commitment to providing Pharmaceutical, Biotech, and Medtech organizations with the most advanced, reliable, and user-friendly AI agents available. These updates represent not just incremental improvements, but fundamental leaps forward in AI capability, performance, and enterprise readiness.

While the broader AI landscape continues to evolve rapidly, our focus remains laser-sharp on delivering practical, validated solutions that address the real-world challenges facing Medical Affairs, Market Access, Regulators or Commercial teams. Each update in Version 3 has been designed with deep industry expertise and validated through close collaboration and co-creation with our pharmaceutical partners.

Here are the key updates in the productive OneRay Version 3 for  June 2025:

AI Engine & Model Upgrades

Next-generation AI capabilities with smarter, faster responses

  • New AI Models: Integrated Claude 3.7 & 4 with enhanced analytical abilities and higher output limits
  • Unified Agent Architecture: Single interface that automatically selects the optimal AI agent for each task
  • Smarter Conversations: Upgraded conversation engine with improved context handling and reduced error rates
  • Optimized Performance: Enhanced token efficiency and multi-level retry logic for seamless user experience

 

Search & Reference Intelligence

Revolutionary improvements in content discovery and accuracy

  • Advanced Referencing Engine: Complete system overhaul with better accuracy, reasoning, and relevance scoring
  • Enhanced Embeddings: Keyword-based optimization delivering 2-4× speed improvements
  • Intelligent Caching: New search caching layer providing 3-8× performance gains
  • Dynamic Content Discovery: Improved Veeva integration with extended metadata and advanced filtering

 

Performance & Scalability

Infrastructure upgrades for enterprise-scale reliability

  • Multi-Level Load Balancing: Enhanced Bedrock load balancing for improved AI performance and scalability
  • Faster Streaming: Significantly improved live chat streaming performance and responsiveness
  • Robust Error Handling: Multi-level retry mechanisms and comprehensive error tracking with Sentry
  • Enhanced File Processing: Improved upload handling with support for large files across all agents

 

User Experience & Interface

Streamlined interactions with modern, responsive design

  • Unified Agent Experience: Single conversation architecture allowing AI to choose the right agents in the background, depending on the question asked by the user.
  • Enhanced Mobile Experience: Better responsive design and mobile usability
  • Interactive Features: “Talking head” avatars with video chunking and improved streaming; ad-hoch download of generated videos
  • Improved Workflows: Conversation continuity, dynamic status updates, and enhanced progress indicators

 

Enterprise Integration & Security

Production-ready features for organizational deployment

  • SSO Integration: Microsoft and Okta Single Sign-On support for seamless authentication
  • Veeva Vault Integration: Full integration with extended metadata and filtering capabilities
  • Enhanced Analytics: Improved tracking and notification systems for better insights
  • Streamlined Deployment: Updated CI/CD pipeline with better environment management for large Pharma scalability

 

OneRay Version 3: Tailored private gen AI for Pharma, BioTech & Medtech functions

genAIagents

OneRay Version 3 introduces an expanded collection of purpose-built AI agents, each designed to address specific challenges in pharmaceutical operations. Our agent portfolio now includes Summary, Comparison, Chat, Validator, Follow-up eMail, Field Companion, Insights, Next Best Action, Quizbots, Tutor, Talking Head HCP Engagement Simulations, Protocol & CSR, Dossier Writing, Systematic Literature Review (SLR), SOP Monitor, HTA Scanner, and Competitor Scanner agents.

These agents work together to support Market Access, Medical Affairs, Regulatory, and Commercial teams with reliable, accurate outputs that reference approved materials. Rather than requiring specialized AI expertise, teams can simply select the agent that matches their task and receive consistent, high-quality results that integrate seamlessly with existing workflows and compliance requirements.

 

The result? AI agents that deliver consistent, high-quality outputs regardless of user experience level, with no prompting required and complete referencing to approved materials. Your teams can focus on what matters most: advancing patient care and medical innovation.

 

Why Choose FFI-Ventures for Your GenAI Journey?

Deep Industry Expertise: With extensive experience in Pharma, Biotech & Medtech, FFI understands the unique challenges, regulatory requirements, and operational complexities that define your daily work.

Proven Integration Approach: We combine cutting-edge generative AI expertise with practical implementation experience, ensuring solutions are tailored to your specific needs and grounded in real-world practicality.